Please select the option that best describes you:
Topics:
Gastrointestinal Cancers • Medical Oncology • Liver and Pancreas Tumors • Cholangiocarcinoma • Inflammatory Bowel Disease • Gastroenterology
How would active Crohn's on Adalimumab affect the adjuvant management of a T2aN0M0 gallbladder cancer?
Would you recommend adjuvant Xeloda?